Skip to main content
. 2020 Dec 29:1–9. doi: 10.1080/17512433.2021.1856655

Table 3.

Top 25 ADEs suspected to be caused by remdesivir reported in 439 individuals in WHO database (N = 439)

Sl. No. ADEs Frequency (%)
1 Hepatic enzyme increased 141 (32.11)
2 Renal Injury 63 (14.4)
3 Blood creatinine increased 49 (11.2)
4 Medication Error 34 (7.7)
5 Product Use in Unapproved Condition 29 (6.6)
6 Respiratory failure 28 (6.4)
7 Tachy or Bradyarrythmia 26 (5.9)
8 Hypotension 24 (5.5)
9 Rash 22 (5.0)
10 Therapy cessation 22 (5.0)
11 Condition Aggravated/Disease Progression 19 (4.3)
12 Sepsis and Septic Shock 18 (4.1)
13 Cardiac and Cardiorespiratory Arrest 17 (3.9)
14 Nausea/Vomiting 15 (3.4)
15 Glomerular filtration rate decreased 14 (3.2)
16 Renal impairment 14 (3.2)
17 Abnormal Hemogram 13 (3.0)
18 Renal failure 13 (3.0)
19 Death 12 (2.7)
20 Multiorgan Disorder/Organ Failure 11 (2.5)
21 Pyrexia 11 (2.5)
22 Hypoxia 11 (2.5)
23 Dialysis 11 (2.5)
24 Diarrhea 10 (2.3)
25 Acidosis 10 (2.3)